Novavax
NVAX
#5744
Rank
S$1.59 B
Marketcap
S$9.64
Share price
-3.24%
Change (1 day)
16.26%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): S-$1.96

According to Novavax's latest financial reports the company's current EPS (TTM) is S-$1.96. In 2025 the company made an earnings per share (EPS) of S$3.53 an increase over its 2024 EPS that were of S-$1.59.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.96-155.53%
2025S$3.53-322.76%
2024S-$1.59
2022S-$10.71-64.36%
2021S-$30.04243%
2020S-$8.7619.75%
2019S-$7.31-43.86%
2018S-$13.03-19.84%
2017S-$16.25-38.83%
2016S-$26.5774.58%
2015S-$15.2263.89%
2014S-$9.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.77-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.18-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$3.71-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S-$3.39 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.61 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$2.61-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S-$0.57-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$1.74-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$6.50 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA